TipRanks
Panacea Biotec Limited (IN:PANACEABIO)
:PANACEABIO
India Market
Want to see IN:PANACEABIO full AI Analyst Report?

Panacea Biotec Limited (PANACEABIO) Ratios

0 Followers

Panacea Biotec Limited Ratios

IN:PANACEABIO's free cash flow for Q1 2027 was ₹0.23. For the 2027 fiscal year, IN:PANACEABIO's free cash flow was decreased by ₹ and operating cash flow was ₹-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
0.00 1.47 1.49 1.57 1.71
Quick Ratio
0.00 0.92 0.90 0.99 1.10
Cash Ratio
0.00 0.18 0.22 0.15 0.12
Solvency Ratio
-0.03 0.06 0.06 0.09 0.01
Operating Cash Flow Ratio
0.00 0.05 -0.07 >-0.01 -1.27
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 -7.68K
Net Current Asset Value
₹ 8.29B₹ 797.50M₹ 860.50M₹ 827.31M₹ 1.37B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.02 0.02 0.02 0.02
Debt-to-Equity Ratio
0.00 0.03 0.03 0.02 0.02
Debt-to-Capital Ratio
0.00 0.03 0.03 0.02 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.03 0.03 0.02 0.02
Financial Leverage Ratio
0.00 1.51 1.54 1.47 1.51
Debt Service Coverage Ratio
2.00 -0.74 7.72 10.77 2.18
Interest Coverage Ratio
-4.77 -6.23 -15.65 -3.86 -23.81
Debt to Market Cap
0.00 0.01 <0.01 0.03 0.03
Interest Debt Per Share
1.04 4.87 4.27 3.99 4.03
Net Debt to EBITDA
0.00 8.74 -1.95 -0.63 -0.35
Profitability Margins
Gross Profit Margin
31.51%22.73%64.31%8.09%38.99%
EBIT Margin
-3.16%-5.90%-0.73%0.92%3.77%
EBITDA Margin
1.68%-0.73%5.50%7.53%12.34%
Operating Profit Margin
-4.52%-5.90%-10.86%-2.50%-23.12%
Pretax Profit Margin
-1.54%-1.15%-1.42%0.27%2.80%
Net Profit Margin
-1.06%-0.84%-1.50%-0.21%-7.27%
Continuous Operations Profit Margin
-1.33%-1.12%-1.56%-0.27%-7.39%
Net Income Per EBT
68.73%72.86%105.28%-79.42%-259.56%
EBT Per EBIT
34.10%19.54%13.09%-10.70%-12.12%
Return on Assets (ROA)
0.00%-0.43%-0.65%-0.09%-2.61%
Return on Equity (ROE)
-0.86%-0.64%-1.00%-0.14%-3.94%
Return on Capital Employed (ROCE)
0.00%-4.13%-6.58%-1.48%-11.25%
Return on Invested Capital (ROIC)
0.00%-4.01%-6.58%1.51%29.64%
Return on Tangible Assets
0.00%-0.44%-0.67%-0.10%-2.67%
Earnings Yield
-0.33%-0.30%-0.30%-0.14%-5.00%
Efficiency Ratios
Receivables Turnover
0.00 8.48 7.44 8.95 7.27
Payables Turnover
0.00 2.61 0.88 1.75 1.57
Inventory Turnover
0.00 2.56 0.93 1.51 1.38
Fixed Asset Turnover
0.00 0.98 0.88 0.87 0.73
Asset Turnover
0.00 0.51 0.43 0.44 0.36
Working Capital Turnover Ratio
8.18 3.74 3.15 2.67 2.03
Cash Conversion Cycle
0.00 45.41 26.93 73.69 82.66
Days of Sales Outstanding
0.00 43.05 49.05 40.78 50.23
Days of Inventory Outstanding
0.00 142.35 390.85 241.48 264.62
Days of Payables Outstanding
0.00 140.00 412.96 208.57 232.18
Operating Cycle
0.00 185.41 439.90 282.25 314.84
Cash Flow Ratios
Operating Cash Flow Per Share
-0.13 2.84 -4.48 -0.02 -68.97
Free Cash Flow Per Share
-4.26 -6.02 -12.71 -12.64 -75.66
CapEx Per Share
4.13 8.86 8.23 12.62 6.68
Free Cash Flow to Operating Cash Flow
33.86 -2.12 2.84 778.18 1.10
Dividend Paid and CapEx Coverage Ratio
-0.03 0.32 -0.54 >-0.01 -10.32
Capital Expenditure Coverage Ratio
-0.03 0.32 -0.54 >-0.01 -10.32
Operating Cash Flow Coverage Ratio
0.00 0.73 -1.23 >-0.01 -20.89
Operating Cash Flow to Sales Ratio
>-0.01 0.03 -0.05 >-0.01 -0.92
Free Cash Flow Yield
-1.19%-2.03%-2.81%-9.56%-69.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-308.28 -336.42 -330.04 -694.27 -19.99
Price-to-Sales (P/S) Ratio
3.26 2.82 4.94 1.48 1.45
Price-to-Book (P/B) Ratio
2.64 2.16 3.31 0.97 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
-84.02 -49.16 -35.56 -10.47 -1.43
Price-to-Operating Cash Flow Ratio
-2.84K 104.19 -100.93 -8.14K -1.57
Price-to-Earnings Growth (PEG) Ratio
2.03 9.41 -0.53 7.19 0.19
Enterprise Value Multiple
194.01 -378.94 87.91 18.98 11.44
Enterprise Value
21.90B 17.66B 27.02B 7.88B 6.45B
EV to EBITDA
194.01 -378.94 87.91 18.98 11.44
EV to Sales
3.26 2.76 4.83 1.43 1.41
EV to Free Cash Flow
-84.02 -48.05 -34.79 -10.13 -1.39
EV to Operating Cash Flow
-2.84K 101.84 -98.74 -7.88K -1.53
Tangible Book Value Per Share
135.33 127.49 129.04 130.28 132.92
Shareholders’ Equity Per Share
135.33 136.81 136.64 136.74 137.73
Tax and Other Ratios
Effective Tax Rate
0.14 0.03 -0.10 2.02 3.64
Revenue Per Share
109.82 104.84 91.51 89.63 74.60
Net Income Per Share
-1.16 -0.88 -1.37 -0.19 -5.43
Tax Burden
0.69 0.73 1.05 -0.79 -2.60
Interest Burden
0.49 0.20 1.95 0.29 0.74
Research & Development to Revenue
0.00 0.00 0.08 0.07 0.07
SG&A to Revenue
0.20 0.29 0.38 0.05 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.25 -3.23 3.44 0.09 -33.00
Currency in INR